X
  • Three researchers from the WVU School of Medicine—Amelia Adcock, Elizabeth Engler-Chiurazzi and Jessica Frey—are investigating whether a treatment called “transcranial magnetic stimulation” can alleviate depressive symptoms in stroke patients. Because prescription antidepressants raise the risk of stroke, they can be a problematic treatment in stroke patients. If TMS proves to be safe and effective, it may become a regular part of the post-stroke treatment regimen.
    Three researchers from the WVU School of Medicine—Amelia Adcock, Elizabeth Engler-Chiurazzi and Jessica Frey—are investigating whether a treatment called “transcranial magnetic stimulation” can alleviate depressive symptoms in stroke patients. Because prescription antidepressants raise the risk of stroke, they can be a problematic treatment in stroke patients. If TMS proves to be safe and effective, it may become a regular part of the post-stroke treatment regimen.
  • Jessica Frey, a neurology resident at WVU, is researching how transcranial magnetic stimulation can ameliorate post-stroke depression. The treatment is a painless procedure that the FDA has approved for treating major depressive disorder that hasn’t responded to conventional treatments. Its use in stroke patients remains largely unexplored.
    Jessica Frey, a neurology resident at WVU, is researching how transcranial magnetic stimulation can ameliorate post-stroke depression. The treatment is a painless procedure that the FDA has approved for treating major depressive disorder that hasn’t responded to conventional treatments. Its use in stroke patients remains largely unexplored.
  • The associate director of WVU’s Stroke Center, Amelia Adcock, is researching whether transcranial magnetic stimulation can treat depression in stroke patients. The FDA has approved TMS for treating major depressive disorder when it doesn’t respond to conventional treatment. Scientists are only now starting to explore how effective TMS can be for depressed stroke patients.
    The associate director of WVU’s Stroke Center, Amelia Adcock, is researching whether transcranial magnetic stimulation can treat depression in stroke patients. The FDA has approved TMS for treating major depressive disorder when it doesn’t respond to conventional treatment. Scientists are only now starting to explore how effective TMS can be for depressed stroke patients.
  • Elizabeth Engler-Chiurazzi is a research assistant professor in the WVU School of Medicine’s Department of Neurology. She is researching how to make depression treatment more effective, including in stroke patients, who are at an increased risk of depression even if their cognitive abilities, motor skills and speech are unaffected.
    Elizabeth Engler-Chiurazzi is a research assistant professor in the WVU School of Medicine’s Department of Neurology. She is researching how to make depression treatment more effective, including in stroke patients, who are at an increased risk of depression even if their cognitive abilities, motor skills and speech are unaffected.
Chat now!